An “innate immunity + local immune activation” combination strategy: Systemic IFN-I and topical TLR7/8-based antitumor immunotherapy strategy
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Sep-2025 01:11 ET (12-Sep-2025 05:11 GMT/UTC)